0000000000559236
AUTHOR
F. Vernuccio
Cardiorenal syndrome: the role of new biochemical markers
Cardiorenal syndrome is a pathophysiological heart and kidney disorder, in which acute or chronic dysfunction of one organ induces a damage in the other. It's a syndrome more and more often encountered in clinical practice and this implies the need to recognize the syndrome through biochemical markers with a good sensitivity and specificity, since its earliest stages in order to optimize therapy. In addition to widely validated biomarkers, such as BNP, pro BNP, creatinine, GFR and cystatin C, other promising molecules are available, like NGAL (neutrophil gelatinase-associated lipocalin, KIM-1 (kidney injury molecule-1), MCP-1 (monocyte chemotactic peptide), Netrin-1, interleuchin 18 and NAG…
Abdominal splenosis and its differential diagnoses: What the radiologist needs to know
Abstract Splenosis is a benign acquired condition characterized by the presence of heterotopic viable splenic tissue in other organs or within cavities such as peritoneum, retroperitoneum, or thorax after splenic trauma or surgery. Abdominal splenosis is often an incidental finding and computed tomography and magnetic resonance usually allow a confident diagnosis. The typical enhancement that parallels the spleen is a useful hallmark of splenosis. Splenic implants lack contrast uptake in the hepatobiliary phase and show high signal at high b-values on diffusion-weighted images. In some cases splenosis may mimic malignant and benign conditions in the peritoneum as well as in hollow and paren…
Radiology for Postmortem
Thanatology deals with the study of early and postmortem changes in relation to the estimation of the time since death. These normal postmortem changes depend on internal and external factors, such as body temperature, preexisting conditions, underlying disease or injury, and the postmortem interval.
Role of imaging in the preoperative assessment of pelvic and extrapelvic endometriosis: a pictorial essay
Aims and objectives Methods and materials Results Conclusion Personal information References
HOW MUCH DANGEROUS IS CT ACCORDING TO PATIENTS AND HOW DOES DOSE BILL AFFECT THEIR PERCEPTION OF IONIZING RADIATION?
Aims and objectives Methods and materials Results Conclusion Personal information References
SAFETY OF REPEATED MDCT WITH CONTRAST COMPOUND IN CASE OF PREVIOUS MILD OR MODERATE ADVERSE REACTION: A SINGLE CENTRE RETROSPECTIVE STUDY.
Aims and objectives Methods and materials Results Conclusion Personal information References
Resectable and borderline resectable pancreatic ductal adenocarcinoma: Role of the radiologist and oncologist in the era of precision medicine
The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation oncology, pathology, geriatric medicine, and palliative care. An adequate staging of pancreatic ductal adenocarcinoma and re-assessment of the tumor after neoadjuvant therapy allows the multidisciplinary team to choose the most appropriate treatment for the patient. This review article discusses advancement in the molecular basis of pancreatic ductal adenocarcinoma, diagnostic tools available fo…
PATIENTS' KNOWLEDGE AND AWARENESS OF RADIATION DOSE AND RISKS FROM CT: DO PATIENTS NEED A PERSONALIZED COMMUNICATION OF DOSE BILL?
Aims and objectives Methods and materials Results Conclusion Personal information References